Filling Prescriptions for Pet Patients: Best Practices
Drug Topics
AUGUST 29, 2023
Filling prescriptions for animals is essentially the same as filling prescriptions for humans—with some key differences.
Tue.Aug 29, 2023
187 
CDC Recommends Beyfortus for Routine Use to Protect Infants, Young Children Against Respiratory Syncytial Virus
Pharmacy Times
AUGUST 29, 2023
Nirsevimab (Beyfortus) is the first respiratory syncytial virus (RSV) preventative drug to be approved by the FDA, and can protect infants through their first RSV season for up to 5 months.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Why Should Independent Pharmacies Stock Pet Medications?
Drug Topics
AUGUST 29, 2023
Caring for pets is easier when a pharmacist is involved.
Supplemental Biologics License Application Submitted to Expand Approval of Rybrevant for NSCLC
Pharmacy Times
AUGUST 29, 2023
The supplemental biologics license application for amivantamab-vmjw (Rybrevant) is supported by data from the phase 3 PAPILLON trial, evaluating the efficacy and safety of the drug in combination with chemotherapy for those with non–small cell lung cancer.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
SSRIs May Mitigate Negative Health Outcomes Associated With Postnatal Depression
Drug Topics
AUGUST 29, 2023
Serotonin reuptake inhibitors (SSRIs) are the preferred medication to treat postnatal depression, but there is a lack of evidence about their long-term impact on women and their children.
Patients With Cancer Engaging in Administrative Payment Tasks May Choose to Delay or Not Adhere to Treatment
Pharmacy Times
AUGUST 29, 2023
Patients with cancer and survivors of cancer that had engaged in administrative tasks to effectively estimate costs or pay for care was associated with an 18% increase in cost-related treatment delays or treatment nonadherence.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Artificial Intelligence for Comprehensive Diagnostics, Examinations in Acute Coronary Syndromes
Pharmacy Times
AUGUST 29, 2023
Pharmacists can actively engage in the implementation of the Comprehensive Diagnostics and Examinations in Acute Coronary Syndromes pathway within the hospital or health care system.
Opinion: How the twin crises of climate change and poor public housing are harming people’s health
STAT
AUGUST 29, 2023
Climate change is an existential problem for human health. As climate change intensifies, the frequency and severity of extreme weather events such as heatwaves, cold fronts, and floods will increase. Undoubtedly, this will result in devastating effects for human health and wellbeing, contributing to increased susceptibility to infectious diseases, an already growing mental health crisis, and, most directly, heat-related mortality.
Study: New Vaccine Modality Using Biopolymer Particles Shows Promise in Group A Streptococcus
Pharmacy Times
AUGUST 29, 2023
Investigators from Griffith University stated that technology has helped the development of vaccines that are safe to use and induce strong immune responses against Strep A.
STAT+: As competition looms, Insulet sues a rival for allegedly stealing trade secrets on diabetes tech
STAT
AUGUST 29, 2023
Insulet filed a lawsuit this month against its rival EOFlow, accusing it of stealing trade secrets in a case that could shake up the diabetes technology market and throw a wrench in Medtronic’s planned $738 million acquisition of EOFlow. Insulet alleges that the South Korea-based EOFlow copied the design for its only product, a patch pump, called the Omnipod that delivers insulin to people with diabetes.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
FDA Approves Luspatercept-aamt for First-Line Treatment of Anemia in Adults With Lower-Risk Myelodysplastic Syndromes
Pharmacy Times
AUGUST 29, 2023
Luspatercept-aamt (Reblozyl) approved to treat adults with very low- to intermediate-risk myelodysplastic syndrome who may require regular red blood cell transfusions.
CDC calls for hospitals to 'raise the bar on sepsis care' with new program guidance
Fierce Healthcare
AUGUST 29, 2023
Sepsis is a factor among roughly 1 in 3 hospital deaths, yet, as of last year, more than a quarter of hospitals didn’t have a formal sepsis committee in place and nearly half said they did not prov | The agency's Hospital Sepsis Program Core Elements is a free resource center for hospitals beginning or refining their efforts to identify and address sepsis in their facilities.
Learn the short- and long-term effects of Adderall on the body
The Checkup by Singlecare
AUGUST 29, 2023
If you have attention-deficit/hyperactivity disorder (ADHD), your healthcare provider may recommend or prescribe the stimulant medication Adderall to help minimize your symptoms. Adderall can be an essential tool for improving the daily executive functioning of people with ADHD. It helps with thinking more clearly, focusing energy on singular projects, and coping better with everyday challenges like impulsivity and hyperactivity.
Clinical trials: How AI can help providers stay TMF inspection-ready
Pharmaceutical Technology
AUGUST 29, 2023
The clinical trials industry is facing a number of hurdles, but AI and digitalisation are being heralded as key to overcoming them, particularly when it comes to preparing for inspections and audits
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Opinion: Every senator should fill out a legislative advance directive
STAT
AUGUST 29, 2023
Advance directives were born in the Senate. Now they can help preserve the dignity of its aging members. In Cruzan v. Director, Missouri Department of Health , the parents of Nancy Cruzan, a young woman who had been left in a permanent vegetative state after a car accident, wanted the right to remove her life support. In 1990, the Supreme Court ruled in favor of her parents, affirming the constitutional right to refuse life-sustaining treatment.
From Shortages to Solutions: Enhancing Drug Manufacturing Through Innovation
Pharmacy Times
AUGUST 29, 2023
Technology and regulations can revolutionize drug manufacturing and ensure a stable supply of medications.
With Novo's Wegovy on the rise, AstraZeneca's Ruud Dobber thinks Farxiga can hold its own
Fierce Pharma
AUGUST 29, 2023
GLP-1 agonists such as Novo Nordisk’s semaglutide and SGLT2 inhibitors like AstraZeneca’s Farxiga are already butting heads in the treatment of diabetes. | GLP-1 agonists such as Novo Nordisk’s semaglutide and SGLT2 inhibitors like AstraZeneca’s Farxiga are already bumping heads in diabetes treatment. AstraZeneca’s biopharma business president, Ruud Dobber, said he’s not concerned about a potential upcoming clash between the two classes in heart failure.
Overcoming the challenges of HIPAA-compliant marketing, analytics & advertising
Fierce Healthcare
AUGUST 29, 2023
Healthcare providers continue to misuse patient data | HIPAA compliance is challenging, but healthcare organizations must cultivate it in all their operations, including marketing activities.
Drugs from J&J, Merck, Novartis, BMS and more set for first round of Medicare price negotiations: CMS
Fierce Pharma
AUGUST 29, 2023
The day drugmakers have been dreading has arrived: Tuesday, the Centers for Medicare & Medicaid Services (CMS) unveiled its list of 10 drugs up for the first price negotiations under the Inflat | The drugs that made the cut for the first price negotiations are Johnson & Johnson’s Imbruvica, Stelara and Xarelto plus Bristol Myers Squibb’s Eliquis, Merck & Co.’s Januvia, Novartis’ Entresto, Eli Lilly’s Jardiance, AstraZeneca’s Farxiga, Novo Nordisk’s Fiasp and Amgen’s Enbrel.
Anthem launching AI-enabled virtual-first plans in 2 more states
Fierce Healthcare
AUGUST 29, 2023
Earlier this year, Anthem Blue Cross and Blue Shield unveiled a new virtual-first plan that harnesses artificial intelligence to streamline health services for members, the insurer
‘We need to do better:’ A biotech CEO on standing apart from the crowd
PharmaVoice
AUGUST 29, 2023
The CEO of Cullinan Oncology is taking a small biotech to the next step and believes the temporary financial barriers are smaller than scientific progress.
Bristol Myers Squibb's Reblozyl, chasing $4B sales target, wins key FDA label expansion
Fierce Pharma
AUGUST 29, 2023
As Bristol lays off staffers and works through the painful loss of exclusivity for | The first-line anemia use in MDS represents a key milestone as Bristol Myers targets $4 billion in peak sales for the new medicine.
Mallinckrodt files for second bankruptcy
Drug Store News
AUGUST 29, 2023
Mallinckrodt said it intends to pay vendors and suppliers in the ordinary course, including for any pre-petition amounts owed at the time of filing.
European regulatory perspective on nitrosamine mitigation strategies
European Pharmaceutical Review
AUGUST 29, 2023
Experts at the European Medicines Agency (EMA) have provided a regulatory perspective on risk factors and mitigation strategies for nitrosamine impurities in human drug products. The paper highlighted an Article 31 referral into medicine safety which began in the EU in September 2019. Above acceptable levels of N-nitrosodimethylamine (NDMA) had been detected in ranitidine tablets and thus investigated.
How to Better Invest in Your Pharmacy’s Future
PioneerRx
AUGUST 29, 2023
Pharmacy work is an ongoing journey. Whether we’re talking about your fill queue, vaccine quotas, or your patient’s health journey, the work of an independent.
Roche subcutaneous cancer immunotherapy granted MHRA approval
European Pharmaceutical Review
AUGUST 29, 2023
The Medicines and Healthcare Products Regulatory Agency (MHRA) has authorised the first subcutaneous formulation of an anti-PD-(L)1 cancer immunotherapy to be made available to patients in Great Britain. Administration of Roche’s Tecentriq ® SC (atezolizumab) takes approximately seven minutes. This is compared to 30-60 minutes via intravenous (IV) administration.
Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation
Fierce Pharma
AUGUST 29, 2023
As Moderna’s COVID vaccine patent lawsuits wind their way through courts around the globe, Pfizer and BioNTech contend their rival is trying to monopolize the entire mRNA field. | Pfizer and BioNTech have filed a pair of petitions seeking to invalidate two Moderna patents at the heart of the legal proceedings between the mRNA juggernauts.
Three-Way Collaboration Between Rentschler Biopharma, CGT Catapult, and Refeyn Aims to Improve PAT for Gene Therapy Manufacturing
BioPharm
AUGUST 29, 2023
Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.
Walmart reportedly cutting pharmacists' pay, hours
Drug Store News
AUGUST 29, 2023
The cuts are aimed at pharmacists in higher wage brackets and underscore the new pressures at Walmart pharmacies, per a Reuters report.
Highmark posts $13.6B in H1 revenue as volumes rise at Allegheny Health Network
Fierce Healthcare
AUGUST 29, 2023
Highmark Health reported $13.6 billion in revenue for the first half of 2023 as well as $389 million in net income. | Highmark Health reported $13.6 billion in revenue for the first half of 2023 as well as $389 million in net income.
Janssen Seeks FDA Approval for Kinase Inhibitor to Treat Metastatic, Genetically-Altered Bladder Cancer
Pharmacy Times
AUGUST 29, 2023
The kinase inhibitor is already approved for patients who experienced recurrence following 1 or more lines of standard of care platinum-containing chemotherapy.
BlueRock clears key hurdle in Parkinson's stem cell trial
pharmaphorum
AUGUST 29, 2023
BlueRock clears key hurdle in Parkinson's stem cell trial Phil.
Study: Women With Chronic Fatigue Tend to Have More Symptoms, Co-Occurring Conditions Than Men
Pharmacy Times
AUGUST 29, 2023
Women with myalgic encephalomyelitis/chronic fatigue syndrome for more than 10 years are more likely to have increased severity in their symptoms as they age.
Biden names 10 drugs for first negotiations to cut Medicare prices
The Guardian - Pharmaceutical Industry
AUGUST 29, 2023
Government claims prices could fall for 9m seniors but pharma companies claim cost-reduction program is unconstitutional The Biden administration has selected 10 drugs for the first round of price negotiations between Medicare and pharmaceutical companies in an effort to lower costs for seniors, it announced on Tuesday. The list of prescription drugs includes blood thinners and treatments for diabetes, as well as drugs used to treat kidney disease, heart failure and arthritis.
Let's personalize your content